These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24980156)

  • 1. Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Hu YM; Li J; Yu LC; Shi SB; Du YJ; Wu JN; Shi WL
    Pathol Oncol Res; 2015 Apr; 21(2):257-65. PubMed ID: 24980156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin mRNA expression in blood as a predictor of the response to EGFR-tyrosine kinase inhibitors and prognosis in patients with non-small cell lung cancer.
    Shi WL; Li J; Bao QL; Wu JN; Ge LP; Zhu LR; Wang Y; Zhu WF
    Med Oncol; 2014 Apr; 31(4):893. PubMed ID: 24563335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
    Tang XP; Li J; Yu LC; Chen YC; Shi SB; Zhu LR; Chen P
    Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin mRNA-circulating tumor cells predict treatment efficacy of chemotherapy and survival for advanced non-small cell lung cancer patients.
    Du YJ; Li J; Zhu WF; Wu Y; Tang XP; Wang Y; Hu YM
    Tumour Biol; 2014 May; 35(5):4499-507. PubMed ID: 24390669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
    AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carbohydrate antigen 12-5 level enhances the prognostic value in primary adenosquamous carcinoma of the lung: a two-institutional experience.
    Lian S; Huang Y; Yang H; Zhao H
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):419-24. PubMed ID: 27002010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
    Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
    Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P; Li J; Ge LP; Dai CH; Li XQ
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
    Xu YP; Li B; Xu XL; Mao WM
    Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.
    Ripley RT; Suzuki K; Tan KS; Adusumilli PS; Huang J; Park BJ; Downey RJ; Rizk NP; Rusch VW; Bains M; Jones DR
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):969-77, 979.e1-3. PubMed ID: 26614420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
    Duan H; Liang L; Xie S; Wang C
    BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
    Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
    Xu X; Zhu S; Tao Z; Ye S
    Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients 
Treated with Surgery].
    Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
    Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.